Back to Agenda
PPD Innovation Theater: Reimagining Study Planning and Feasibility to Create More Efficient Clinical Trials
Session Chair(s)
PPD, part of Thermo Fisher Scientific
United States
Traditional study planning, driven by the number of sites estimated to achieve enrollment, is filled with inefficiencies and significant delays. Together with a key client, PPD’s Accelerated Enrollment Solutions business unit pioneered a new way to integrate the site network into study design to drastically reduces startup times and increases consistency/quality of data and study conduct. This new model is helping bring a lipid-lowering therapy with potential to change millions of lives to market in unprecedented timelines. This case study presentation highlights:
- Shared sense of purpose and accountability across this program to deliver for the greater good and impact to global healthcare system
- Change management on a global- and industry- scale to change the longstanding approach to study startup
- Collaboration to generate evidence: unified to overcome obstacles and nimble to develop new approaches
- The combination of patient data, modeling, direct marketing, predictive analytics to identify qualified patients and deliver enrollment volume and certainty
This unique approach illustrates how a sponsor and CRO can come together to change the face of drug development.
Speaker(s)
Peter Wijngaard, PhD
Peter Wijngaard, PhD
The Medicines Company, United States
Executive Vice President and Chief Development Officer
Tammy D’Lugin-Monroe
Tammy D’Lugin-Monroe
PPD, United States
Exec. Dir. & Global Operations Lead
Have an account?